Holen Sie sich die Stockscreener-App
14.07
3.38%
0.46
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$13.61
Offen:
$13.74
24-Stunden-Volumen:
189.42K
Relative Volume:
0.49
Marktkapitalisierung:
$606.87M
Einnahmen:
$159.01M
Nettoeinkommen (Verlust:
$-21.72M
KGV:
-25.12
EPS:
-0.56
Netto-Cashflow:
$-20.63M
1W Leistung:
+9.07%
1M Leistung:
+5.71%
6M Leistung:
+124.40%
1J Leistung:
+135.28%
1-Tages-Spanne:
$13.63
$14.11
1-Wochen-Bereich:
$12.73
$14.11
52-Wochen-Spanne:
$5.55
$15.90
Axogen Inc Stock (AXGN) Company Profile
Firmenname
Axogen Inc
Sektor
Branche
Telefon
(386) 462-6817
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Vergleichen Sie AXGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
14.07 | 606.87M | 159.01M | -21.72M | -20.63M | -0.56 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-01 | Eingeleitet | Raymond James | Outperform |
| 2022-11-11 | Fortgesetzt | Jefferies | Buy |
| 2022-05-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Eingeleitet | Guggenheim | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-03-02 | Bestätigt | Lake Street | Buy |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Eingeleitet | Jefferies | Buy |
| 2017-11-21 | Bestätigt | Lake Street | Buy |
| 2017-07-31 | Eingeleitet | Leerink Partners | Outperform |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Eingeleitet | ROTH Capital | Buy |
| 2016-11-22 | Hochstufung | Lake Street | Hold → Buy |
| 2016-11-07 | Bestätigt | Wedbush | Outperform |
| 2016-11-03 | Herabstufung | Lake Street | Buy → Hold |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2014-05-14 | Eingeleitet | Dawson James | Buy |
| 2013-10-31 | Bestätigt | Ladenburg Thalmann | Buy |
Alle ansehen
Axogen Inc Aktie (AXGN) Neueste Nachrichten
Leerink Partnrs Issues Positive Forecast for AxoGen Earnings - MarketBeat
Eagle Asset Management Inc. Takes Position in AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
Principal Financial Group Inc. Makes New Investment in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
How Much Upside is Left in AxoGen (AXGN)? Wall Street Analysts Think 31.18% - Yahoo Finance
Connor Clark & Lunn Investment Management Ltd. Buys 123,118 Shares of AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
11,095 Shares in AxoGen, Inc. (NASDAQ:AXGN) Purchased by Oppenheimer & Co. Inc. - Defense World
(AXGN) Technical Data - Stock Traders Daily
AxoGen, Inc. (NASDAQ:AXGN) Sees Significant Decline in Short Interest - MarketBeat
Axogen Inc (AXGN) Shares Down 5.01% on Nov 12 - GuruFocus.com
AxoGen's SWOT analysis: nerve repair firm's stock faces growth hurdles By Investing.com - Investing.com UK
AxoGen's SWOT analysis: nerve repair firm's stock faces growth hurdles - Investing.com India
AxoGen, Inc. (NASDAQ:AXGN) Q3 2024 Earnings Call Transcript - Insider Monkey
Recent 9.2% pullback isn't enough to hurt long-term Axogen (NASDAQ:AXGN) shareholders, they're still up 152% over 1 year - Simply Wall St
Axogen Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Creative Planning Has $418,000 Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen Reports Strong Q3 2024 Revenue Growth - Yahoo Finance
Axogen Inc (AXGN) Q3 2024 Earnings Call Highlights: Strong Reven - GuruFocus.com
Axogen Inc (AXGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements - Investing.com Canada
Axogen Reports Strong Q3 Growth and FDA Progress - TipRanks
Axogen Inc earnings beat by $0.06, revenue topped estimates - Investing.com
AxoGen Q3 2024 Earnings Preview - MSN
First Light Asset Management, LLC Increases Stake in Axogen Inc - GuruFocus.com
SYK: 3 Medical Devices Stocks Poised for Solid Growth - StockNews.com
AxoGen (NASDAQ:AXGN) Trading Down 11.2%Here's Why - MarketBeat
Analysts Predict How High Axogen Inc (AXGN) Will Go. - Stocks Register
Axogen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
AxoGen: Q3 Earnings Snapshot - Marketscreener.com
Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update - GlobeNewswire
Axogen stock soars to 52-week high, hits $15.24 amid robust gains - Investing.com Australia
AxoGen (NASDAQ:AXGN) Hits New 12-Month HighHere's Why - MarketBeat
Axogen Inc (AXGN) Shares Up 3.84% on Nov 4 - GuruFocus.com
AxoGen (AXGN) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
When (AXGN) Moves Investors should Listen - Stock Traders Daily
Director Gregory Freitag Sells 25,000 Shares of Axogen Inc (AXGN) - GuruFocus.com
Semanteon Capital Management LP Acquires New Position in AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024 - GlobeNewswire
Axogen (STU:LT3) Cyclically Adjusted PS Ratio : 4.57 (As of Oct. 23, 2024) - GuruFocus.com
South Korea Peripheral Nerve Injury Market Size & Outlook, 2030 - Grand View Research
Colombia Peripheral Nerve Injury Market Size & Outlook, 2030 - Grand View Research
nVerses Capital LLC Acquires Shares of 4,000 AxoGen, Inc. (NASDAQ:AXGN) - Defense World
(AXGN) Investment Analysis - Stock Traders Daily
FY2028 EPS Estimates for AxoGen Cut by Leerink Partnrs - Defense World
AxoGen (AXGN) Surges 8.2%: Is This an Indication of Further Gains? - MSN
Axogen, Inc. (NASDAQ:AXGN): Are Analysts Optimistic? - Simply Wall St
Leerink Partnrs Has Weak Outlook for AxoGen FY2028 Earnings - MarketBeat
AxoGen (NASDAQ:AXGN) Stock Price Down 4.3%Should You Sell? - MarketBeat
Exchange Traded Concepts LLC Reduces Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
Axogen Inc (AXGN) Stock Price Down 3.7% on Oct 17 - GuruFocus.com
AxoGen (NASDAQ:AXGN) Reaches New 52-Week HighTime to Buy? - MarketBeat
Axogen stock soars to 52-week high, hits $15.12 amid robust gains - Investing.com Australia
Finanzdaten der Axogen Inc-Aktie (AXGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):